Public Employees Retirement Association of Colorado acquired a new stake in PRA Health Sciences Inc (NASDAQ:PRAH) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 5,850 shares of the medical research company’s stock, valued at approximately $533,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. IFP Advisors Inc raised its holdings in PRA Health Sciences by 19,083.3% in the 4th quarter. IFP Advisors Inc now owns 1,151 shares of the medical research company’s stock valued at $105,000 after buying an additional 1,145 shares during the last quarter. Carroll Financial Associates Inc. raised its holdings in PRA Health Sciences by 127.4% during the 3rd quarter. Carroll Financial Associates Inc. now owns 1,410 shares of the medical research company’s stock worth $112,000 after purchasing an additional 790 shares during the last quarter. Parametrica Management Ltd bought a new position in PRA Health Sciences during the 4th quarter worth approximately $232,000. Comerica Bank bought a new position in PRA Health Sciences during the 3rd quarter worth approximately $214,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in PRA Health Sciences by 82.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,069 shares of the medical research company’s stock worth $279,000 after purchasing an additional 1,388 shares during the last quarter. Institutional investors and hedge funds own 96.92% of the company’s stock.
Several research analysts have issued reports on PRAH shares. Jefferies Group restated a “buy” rating and set a $95.00 price target on shares of PRA Health Sciences in a report on Thursday, October 26th. Credit Suisse Group raised their price target on shares of PRA Health Sciences from $90.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, October 26th. SunTrust Banks restated a “buy” rating and set a $101.00 price target on shares of PRA Health Sciences in a report on Friday, October 27th. KeyCorp restated a “buy” rating and set a $93.00 price target (up previously from $86.00) on shares of PRA Health Sciences in a report on Monday, October 30th. Finally, Mizuho set a $87.00 price target on shares of PRA Health Sciences and gave the stock a “buy” rating in a report on Friday, December 1st. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $92.31.
In other news, VP Linda Baddour sold 67,000 shares of PRA Health Sciences stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $90.27, for a total value of $6,048,090.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP David W. Dockhorn sold 72,850 shares of PRA Health Sciences stock in a transaction on Thursday, December 28th. The shares were sold at an average price of $90.83, for a total transaction of $6,616,965.50. Following the completion of the sale, the executive vice president now owns 72,850 shares of the company’s stock, valued at approximately $6,616,965.50. The disclosure for this sale can be found here. Insiders sold a total of 212,700 shares of company stock valued at $19,282,021 in the last quarter. 2.10% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Public Employees Retirement Association of Colorado Invests $533,000 in PRA Health Sciences Inc (PRAH) Stock” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://stocknewstimes.com/2018/02/19/public-employees-retirement-association-of-colorado-invests-533000-in-pra-health-sciences-inc-prah-stock.html.
About PRA Health Sciences
PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.
Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).
Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.